Etrolizumab

Tidak ditemukan merek terdaftar untuk zat aktif ini.

Tidak ada catatan makanan tercatat untuk zat aktif ini.

• AbciximabMODERAT

  Mengonsumsi Abciximab bersama Etrolizumab dapat meningkatkan risiko atau keparahan efek samping.

  Tampilan ahli

  The risk or severity of adverse effects can be increased when Abciximab is combined with Etrolizumab.

• AdalimumabMODERAT

  Mengonsumsi Adalimumab bersama Etrolizumab dapat meningkatkan risiko atau keparahan efek samping.

  Tampilan ahli

  The risk or severity of adverse effects can be increased when Adalimumab is combined with Etrolizumab.

• AdecatumumabMODERAT

  Mengonsumsi Adecatumumab bersama Etrolizumab dapat meningkatkan risiko atau keparahan efek samping.

  Tampilan ahli

  The risk or severity of adverse effects can be increased when Adecatumumab is combined with Etrolizumab.

• AfelimomabMODERAT

  Mengonsumsi Afelimomab bersama Etrolizumab dapat meningkatkan risiko atau keparahan efek samping.

  Tampilan ahli

  The risk or severity of adverse effects can be increased when Afelimomab is combined with Etrolizumab.

• AlemtuzumabMODERAT

  Mengonsumsi Alemtuzumab bersama Etrolizumab dapat meningkatkan risiko atau keparahan efek samping.

  Tampilan ahli

  The risk or severity of adverse effects can be increased when Alemtuzumab is combined with Etrolizumab.

• AlirocumabMODERAT

  Mengonsumsi Alirocumab bersama Etrolizumab dapat meningkatkan risiko atau keparahan efek samping.

  Tampilan ahli

  The risk or severity of adverse effects can be increased when Alirocumab is combined with Etrolizumab.

• AMG 108MODERAT

  Mengonsumsi AMG 108 bersama Etrolizumab dapat meningkatkan risiko atau keparahan efek samping.

  Tampilan ahli

  The risk or severity of adverse effects can be increased when AMG 108 is combined with Etrolizumab.

• AnifrolumabMODERAT

  Mengonsumsi Anifrolumab bersama Etrolizumab dapat meningkatkan risiko atau keparahan efek samping.

  Tampilan ahli

  The risk or severity of adverse effects can be increased when Anifrolumab is combined with Etrolizumab.

• Anthrax immune globulin humanMODERAT

  Mengonsumsi Anthrax immune globulin human bersama Etrolizumab dapat meningkatkan risiko atau keparahan efek samping.

  Tampilan ahli

  The risk or severity of adverse effects can be increased when Anthrax immune globulin human is combined with Etrolizumab.

• Antilymphocyte immunoglobulin (horse)MODERAT

  Mengonsumsi Antilymphocyte immunoglobulin (horse) bersama Etrolizumab dapat meningkatkan risiko atau keparahan efek samping.

  Tampilan ahli

  The risk or severity of adverse effects can be increased when Antilymphocyte immunoglobulin (horse) is combined with Etrolizumab.